Literature DB >> 7358518

VIP in the rat brain: evidence for a major pathway linking the amygdala and hypothalamus via the stria terminalis.

G W Roberts, P L Woodhams, M G Bryant, T J Crow, S R Bloom, J M Polak.   

Abstract

We report here on the detailed distribution of VIP-like immunoreactivity in the rat brain by a combined immunological approach using immunocytochemistry and radioimmunoassay. VIP-like immunoreactivity was widely distributed. Cell bodies and and fibres were noted principally in the cortex, hippocampus, amygdala, suprachiasmatic nucleus and brain stem. In addition dense areas of immunoreactive fibres and terminals were seen in the stria terminalis and its bed nucleus. The fibres appear to form a major VIP-containing pathway which links the amygdaloid complex with the hypothalamus. Although the functional significance of VIP in the brain is unknown, its presence in the amygdala, the hypothalamus and their linking pathway, as well as its pharmacological actions suggest that it may play a role in neuroendocrine regulation and the modulation of hypothalamic function.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7358518     DOI: 10.1007/bf00493159

Source DB:  PubMed          Journal:  Histochemistry        ISSN: 0301-5564


  25 in total

1.  Regional and subcellular distributions of brain neurotensin.

Authors:  G R Uhl; S H Snyder
Journal:  Life Sci       Date:  1976-12-15       Impact factor: 5.037

Review 2.  Distribution of putative neurotransmitters in the neocortex.

Authors:  P C Emson; O Lindvall
Journal:  Neuroscience       Date:  1979       Impact factor: 3.590

3.  Vasoactive intestinal polypeptide: specific binding to rat brain membranes.

Authors:  D P Taylor; C B Pert
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

4.  Distribution of substance P-like immunoreactivity in the central nervous system of the rat--I. Cell bodies and nerve terminals.

Authors:  A Ljungdahl; T Hökfelt; G Nilsson
Journal:  Neuroscience       Date:  1978       Impact factor: 3.590

5.  Release of gonadotropins induced by amygdaloid stimulation in the rat.

Authors:  M E Velasco; S Taleisnik
Journal:  Endocrinology       Date:  1969-01       Impact factor: 4.736

6.  Measurement of fasting and postprandial plasma VIP in man.

Authors:  S J Mitchell; S R Bloom
Journal:  Gut       Date:  1978-11       Impact factor: 23.059

7.  Possible dual role for vasoactive intestinal peptide as gastrointestinal hormone and neurotransmitter substance.

Authors:  M G Bryant; M M Polak; I Modlin; S R Bloom; R H Albuquerque; A G Pearse
Journal:  Lancet       Date:  1976-05-08       Impact factor: 79.321

8.  Excitation of CA1 neurones of the rat hippocampus by the octacosapeptide, vasoactive intestinal polypeptide (VIP) [proceedings].

Authors:  J Dodd; J S Kelly; S I Said
Journal:  Br J Pharmacol       Date:  1979-05       Impact factor: 8.739

9.  Vasoactive intestinal polypeptide and the nervous system: immunohistochemical evidence for localization in central and peripheral neurons, particularly intracortical neurons of the cerebral cortex.

Authors:  K Fuxe; T Hökfelt; S I Said; V Mutt
Journal:  Neurosci Lett       Date:  1977-08       Impact factor: 3.046

10.  Effect of vasoactive intestinal peptide (VIP) and other peptides on cAMP accumulation in rat brain.

Authors:  M Quik; L L Iversen; S R Bloom
Journal:  Biochem Pharmacol       Date:  1978       Impact factor: 5.858

View more
  14 in total

1.  Ultrastructure of cerebrospinal fluid-contacting neurons immunoreactive to vasoactive intestinal peptide and properties of the blood-brain barrier in the lateral septal organ of the duck.

Authors:  K Hirunagi; E Rommel; H W Korf
Journal:  Cell Tissue Res       Date:  1995-01       Impact factor: 5.249

2.  The differential distribution of vasoactive intestinal polypeptide in the normal human female genital tract.

Authors:  E M Lynch; J Wharton; M G Bryant; S R Bloom; J M Polak; M G Elder
Journal:  Histochemistry       Date:  1980

3.  Structure and expression of the gene encoding the vasoactive intestinal peptide precursor.

Authors:  S Linder; T Barkhem; A Norberg; H Persson; M Schalling; T Hökfelt; G Magnusson
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

4.  Immunocytochemical analysis of calcitonin gene-related peptide and vasoactive intestinal polypeptide in Merkel cells and cutaneous free nerve endings of cats.

Authors:  F J Alvarez; C Cervantes; R Villalba; I Blasco; R Martínez-Murillo; J M Polak; J Rodrigo
Journal:  Cell Tissue Res       Date:  1988-11       Impact factor: 5.249

Review 5.  Vasoactive intestinal peptide and the mammalian circadian system.

Authors:  Andrew M Vosko; Analyne Schroeder; Dawn H Loh; Christopher S Colwell
Journal:  Gen Comp Endocrinol       Date:  2007-05-26       Impact factor: 2.822

6.  Neuropeptide localisation in the substantia innominata and adjacent regions of the human brain.

Authors:  J M Candy; R H Perry; J E Thompson; M Johnson; A E Oakley
Journal:  J Anat       Date:  1985-03       Impact factor: 2.610

7.  Somatostatin and vasoactive intestinal polypeptide-like immunoreactive cells and terminals in the retrohippocampal region of the rat brain.

Authors:  C Köhler; V Chan-Palay
Journal:  Anat Embryol (Berl)       Date:  1983

Review 8.  Neuroendocrine regulation of thyrotropin-releasing hormone (TRH) in the tuberoinfundibular system.

Authors:  R Toni; R M Lechan
Journal:  J Endocrinol Invest       Date:  1993-10       Impact factor: 4.256

9.  Localization of DARPP-32 immunoreactive neurons in the bed nucleus of the stria terminalis and central nucleus of the amygdala: co-distribution with axons containing tyrosine hydroxylase, vasoactive intestinal polypeptide, and calcitonin gene-related peptide.

Authors:  E L Gustafson; P Greengard
Journal:  Exp Brain Res       Date:  1990       Impact factor: 1.972

10.  Identification of serotonin- and vasopressin immunoreactivities in the suprachiasmatic nucleus of four mammalian species.

Authors:  S Ueda; M Kawata; Y Sano
Journal:  Cell Tissue Res       Date:  1983       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.